An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer

Authors

Naveenchandra Suryadevara, Vanderbilt University
Laura A. VanBlargan, Washington University School of Medicine in St. Louis
Rita E. Chen, Washington University School of Medicine in St. Louis
James Brett Case, Washington University School of Medicine in St. Louis
Michael S. Diamond, Washington University School of Medicine in St. Louis
et al

Journal

Journal of Clinical Investigation

Publication Date

6-1-2022

Volume

132

Issue

11

First Page

e159062

Document Type

Open Access Publication

DOI

10.1172/JCI159062

Rights and Permissions

Suryadevara N, Shiakolas AR, VanBlargan LA, Binshtein E, Chen RE, Case JB, Kramer KJ, Armstrong EC, Myers L, Trivette A, Gainza C, Nargi RS, Selverian CN, Davidson E, Doranz BJ, Diaz SM, Handal LS, Carnahan RH, Diamond MS, Georgiev IS, Crowe JE Jr. An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer. J Clin Invest. 2022 Jun 1;132(11):e159062. doi: 10.1172/JCI159062. Copyright: © 2022, Suryadevara et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.

Recommended Citation

Suryadevara, Naveenchandra; VanBlargan, Laura A.; Chen, Rita E.; Case, James Brett; Diamond, Michael S.; and et al, "An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer." Journal of Clinical Investigation. 132, 11. e159062 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11984